Research ArticleArticle

Validity and Reliability Problems with Patient Global as a Component of the ACR/EULAR Remission Criteria as Used in Clinical Practice

KARIM R. MASRI, TIMOTHY S. SHAVER, SHADI H. SHAHOURI, SHIRLEY WANG, JAMES D. ANDERSON, RUTH E. BUSCH, KALEB MICHAUD, TED R. MIKULS, LIRON CAPLAN and FREDERICK WOLFE
The Journal of Rheumatology June 2012, 39 (6) 1139-1145; DOI: https://doi.org/10.3899/jrheum.111543

REFERENCES

  1. 1.↵
    1. Felson DT,
    2. Smolen JS,
    3. Wells G,
    4. Zhang B,
    5. van Tuyl LH,
    6. Funovits J,
    7. et al.
    American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum 2011;63:573–86.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Aletaha D,
    2. Smolen JS
    . The Simplified Disease Activity Index (SDAI) and Clinical Disease Activity Index (CDAI) to monitor patients in standard clinical care. Best Pract Res Clin Rheumatol 2007;21:663–75.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Shahouri SH,
    2. Michaud K,
    3. Mikuls TR,
    4. Caplan L,
    5. Shaver TS,
    6. Anderson JD,
    7. et al.
    Remission of rheumatoid arthritis in clinical practice: Application of the American College of Rheumatology/European League Against Rheumatism 2011 remission criteria. Arthritis Rheum 2011;63:3204–15.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Khan NA,
    2. Spencer HJ,
    3. Abda E,
    4. Aggarwal A,
    5. Alten R,
    6. Ancuta C,
    7. et al.
    Determinants of discordance in patients’ and physicians’ rating of rheumatoid arthritis disease activity. Arthritis Care Res 2012;64:206–14.
    OpenUrlCrossRef
  5. 5.↵
    1. Shaver TS,
    2. Anderson JD,
    3. Weidensaul DN,
    4. Shahouri SS,
    5. Busch RE,
    6. Mikuls TR,
    7. et al.
    The problem of rheumatoid arthritis disease activity and remission in clinical practice. J Rheumatol 2008;35:1015–22.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Fuchs HA,
    2. Brooks RH,
    3. Callahan LF,
    4. Pincus T
    . A simplified twenty-eight-joint quantitative articular index in rheumatoid arthritis. Arthritis Rheum 1989;32:531–7.
    OpenUrlPubMed
  7. 7.↵
    1. Wolfe F,
    2. Michaud K,
    3. Pincus T
    . Development and validation of the Health Assessment Questionnaire II: A revised version of the Health Assessment Questionnaire. Arthritis Rheum 2004;50:3296–305.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Brummett CM,
    2. Hassett AL,
    3. Brummett KA,
    4. Clauw DJ,
    5. Williams DA
    . The Michigan Body Map and its use in assessing the American College of Rheumatology survey criteria for fibromyalgia. Arthritis Rheum 2012; (in press).
  9. 9.↵
    1. Wolfe F,
    2. Michaud K
    . The National Data Bank for rheumatic diseases: A multi-registry rheumatic disease data bank. Rheumatology 2011;50:16–24.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Fransen J,
    2. Langenegger T,
    3. Michel BA,
    4. Stucki G
    . Feasibility and validity of the RADAI, a self-administered rheumatoid arthritis disease activity index. Rheumatology 2000;39:321–7.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Stucki G,
    2. Liang MH,
    3. Stucki S,
    4. Bruhlmann P,
    5. Michel BA
    . A self-administered rheumatoid arthritis disease activity index (RADAI) for epidemiologic research. Psychometric properties and correlation with parameters of disease activity. Arthritis Rheum 1995;38:795–8.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Stata C
    . Stata Statistical Software: Release 11.2. College Station, TX, USA: Stata Corporation; 2009.
  13. 13.↵
    1. Landis J,
    2. Koch G
    . The measurement of observer agreement for categorical data. Biometrics 1977;33:159–74.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Schmitt JS,
    2. Di Fabio RP
    . Reliable change and minimum important difference (MID) proportions facilitated group responsiveness comparisons using individual threshold criteria. J Clin Epidemiol 2004;57:1008–18.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Mehta CR,
    2. Patel NR
    . Exact logistic regression: Theory and examples. Stat Med 1995;14:2143–60.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Pemberton R,
    2. Peirce EG
    . A clinical and statistical study of chronic arthritis based on eleven hundred cases. Am J Med Sci 1927;173:31–58.
    OpenUrlCrossRef
  17. 17.↵
    1. Thompson HE,
    2. Wyatt BL,
    3. Hicks RA
    . Chronic atrophic arthritis. Ann Intern Med 1938;11:1792–805.
    OpenUrl
  18. 18.↵
    1. Pinals RS,
    2. Baum J,
    3. Bland J,
    4. Fosdick WM,
    5. Kaplan SB,
    6. Masi AT,
    7. et al.
    Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 1981;24:1308–15.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Sokka T,
    2. Hetland ML,
    3. Makinen H,
    4. Kautiainen H,
    5. Horslev-Petersen K,
    6. Luukkainen RK,
    7. et al.
    Remission and rheumatoid arthritis: Data on patients receiving usual care in twenty-four countries. Arthritis Rheum 2008;58:2642–51.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. van Tuyl LH,
    2. Vlad SC,
    3. Felson DT,
    4. Wells G,
    5. Boers M
    . Defining remission in rheumatoid arthritis: Results of an initial American College of Rheumatology/European League Against Rheumatism consensus conference. Arthritis Rheum 2009;61:704–10.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Aletaha D,
    2. Ward MM,
    3. Machold KP,
    4. Nell VP,
    5. Stamm T,
    6. Smolen JS
    . Remission and active disease in rheumatoid arthritis: Defining criteria for disease activity states. Arthritis Rheum 2005;52:2625–36.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Mierau M,
    2. Schoels M,
    3. Gonda G,
    4. Fuchs J,
    5. Aletaha D,
    6. Smolen JS
    . Assessing remission in clinical practice. Rheumatology 2007;46:975–9.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Felson DT,
    2. Anderson JJ,
    3. Boers M,
    4. Bombardier C,
    5. Chernoff M,
    6. Fried B,
    7. et al.
    The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum 1993;36:729–40.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Hagen KB,
    2. Kvien TK,
    3. Bjørndal A
    . Musculoskeletal pain and quality of life in patients with noninflammatory joint pain compared to rheumatoid arthritis: A population survey. J Rheumatol 1997;24:1703–9.
    OpenUrlPubMed
  25. 25.↵
    1. Neva MH,
    2. Häkkinen A,
    3. Isomäki P,
    4. Sokka T
    . Chronic back pain in patients with rheumatoid arthritis and in a control population: Prevalence and disability — a 5-year follow-up. Rheumatology 2011;50:1635–9.
    OpenUrlAbstract/FREE Full Text
  26. 26.↵
    1. Wolfe F
    . Determinants of WOMAC function, pain and stiffness scores: Evidence for the role of low back pain, symptom counts, fatigue and depression in osteoarthritis, rheumatoid arthritis and fibromyalgia. Rheumatology 1999;38:355–61.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Bergman MJ,
    2. Shahouri SS,
    3. Shaver TS,
    4. Anderson JD,
    5. Weidensaul DN,
    6. Busch RE,
    7. et al.
    Is fatigue an inflammatory variable in rheumatoid arthritis (RA)? Analyses of fatigue, osteoarthritis, and fibromyalgia. J Rheumatol 2009;36:2788–94.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    1. Bruce B,
    2. Fries J
    . Longitudinal comparison of the Health Assessment Questionnaire (HAQ) and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Arthritis Rheum 2004;51:730–7.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Katz RS,
    2. Wolfe F,
    3. Michaud K
    . Fibromyalgia diagnosis: A comparison of clinical, survey, and American College of Rheumatology criteria. Arthritis Rheum 2006;54:169–76.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Lassere MN,
    2. van der Heijde D,
    3. Johnson KR,
    4. Boers M,
    5. Edmonds J
    . Reliability of measures of disease activity and disease damage in rheumatoid arthritis: Implications for smallest detectable difference, minimal clinically important difference, and analysis of treatment effects in randomized controlled trials. J Rheumatol 2001;28:892–903.
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    1. Dougados M,
    2. Ripert M,
    3. Hilliquin P,
    4. Fardellone P,
    5. Brocq O,
    6. Brault Y,
    7. et al.
    The influence of the definition of patient global assessment in assessment of disease activity according to the Disease Activity Score (DAS28) in rheumatoid arthritis. J Rheumatol 2011;38:2326–8.
    OpenUrlAbstract/FREE Full Text
  32. 32.↵
    1. Gossec L,
    2. Dougados M,
    3. Rincheval N,
    4. Balanescu A,
    5. Boumpas DT,
    6. Canadelo S,
    7. et al.
    Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: A EULAR initiative. Ann Rheum Dis 2009;68:1680–5.
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    1. Sanderson T,
    2. Morris M,
    3. Calnan M,
    4. Richards P,
    5. Hewlett S
    . Patient perspective of measuring treatment efficacy: The rheumatoid arthritis patient priorities for pharmacologic interventions outcomes. Arthritis Care Res 2010;62:647–56.
    OpenUrlCrossRef
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

 Request Permissions

Bookmark this article

Jump to section